CD4 and neoplasm: MMP-9 has been reported to cleave and potentially degrade T-helper cell 1 (Th1)-type chemokines like CXC ligand CXCL10 and inhibit their anti-tumor outcome, including the recruitment of CD4+ T cells and CD8+ T cells, and their tumor-killing effect [27,29,78].